Nexgel (NXGLW) Long-Term Deferred Tax (2021 - 2022)
Nexgel's (NXGLW) quarterly Long-Term Deferred Tax came in at $4.1 million in Q4 2022, up 23.48% YoY from $3.3 million in Q4 2021, and up 23.48% on a QoQ basis from $3.3 million in Q4 2021.
Nexgel (NXGLW) Long-Term Deferred Tax (2021 - 2022) Analysis & Trends
Nexgel (NXGLW) has 2 years of Long-Term Deferred Tax data on file, last reported at $4.1 million in Q4 2022.
- Quarterly Long-Term Deferred Tax rose 23.48% year-over-year to $4.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $4.1 million (up 23.48% YoY) and the FY2022 annual result came in at $4.1 million, up 23.48% from the prior year.
- Long-Term Deferred Tax rose to $4.1 million in Q4 2022, from $3.3 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $4.1 million in Q4 2022 to a low of $3.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.11 Mn |
| Dec 31, 2021 | 3.33 Mn |